Archives

by in
Entry Author Date Location
La Jolla Institute Extends 25-Year Partnership with Japanese Pharma 07/31/13 San Diego
Foundation Medicine Lays Groundwork For $86M IPO 07/29/13 Boston
Agios Prices Upsized IPO Above Range, Preps For Nasdaq Debut 07/24/13 Boston
Why I Won’t Cheer If Onyx Pharma Is Sold for Megabucks 07/15/13 National
Array Starts First Phase 3 Trial, Shifts to Late-Stage Development 07/03/13 Boulder/Denver
Flexion’s Long-Lasting Steroid Injection Hits Mark in Phase 2 Trial 06/26/13 Boston
Constructing Innovation Supply Chains for the Pharmaceutical Industry 06/26/13 Boston
NGM, Partners Seek Next Diabetes Drug Targets Among GI Tract Hormones 06/25/13 San Francisco
East Coast Life Sciences Roundup: Agios, Ludwig/CRI, Celgene 06/14/13 Boston
Immune Design, NY Non-Profits Team Up to Boost Cancer Drugs 06/12/13 Seattle
Agios Files For IPO With Plans to Raise $86M 06/11/13 Boston
AstraZeneca Nabs Redwood City-based Pearl Therapeutics For Up to $1.15B 06/10/13 San Francisco
San Diego Life Sciences Roundup: Zogenix, Isis, Cellana, and More 06/07/13 San Diego
ASCO Wrap-Up: Cancer News from the East, South, & Rockies 06/05/13 National
Isis Execs Upbeat as AstraZeneca Expands Cancer Drug Collaboration 06/05/13 San Diego
East Coast Life Sciences Roundup: Epizyme, Alkermes, Ophthotech, & More 05/31/13 Boston
Regeneron Eyes Potential Blockbuster With Asthma Drug 05/21/13 New York
San Diego Life Sciences Roundup: Optimer, Ambit, AnaptysBio, & More 05/17/13 San Diego
Henri Termeer on Startups, Drug Prices, Getting Older (Part 1) 05/13/13 National
East Coast Life Sciences Roundup: Bind, Gen9, Radius, Cydan 04/26/13 Boston
Cydan, the NEA Startup Machine, Scours the Globe for Orphan Drugs 04/25/13 Boston
Bind Therapeutics, AstraZeneca Collaborate on Cancer Drug 04/22/13 Boston
Meet Ben Fidler, Xconomy’s New East Coast Biotech Editor 04/15/13 New York
East Coast Life Sciences Roundup: Optimer, Bind, Pfizer, and More 04/05/13 Boston
San Diego Life Sciences Roundup: Qualcomm, Amylin, Organovo & More 04/04/13 San Diego
Optimer Shares Soar Amid Reports of Buyout Interest 04/02/13 San Diego
Editor’s Picks: Xconomy Boston’s Top 20 Stories of Q1 2013 04/01/13 Boston
Biotech VCs Aren’t Lemmings Anymore. They’re Lone Rangers 03/25/13 National
East Coast Biotech Roundup: Moderna, bluebird, Blueprint 03/22/13 Boston
AstraZeneca Shells Out $240M Upfront For Moderna mRNA Drugs 03/21/13 Boston
Page 2 of 6 « previous page · next page »